News Headline Summary

Novartis (NOVN VX) CEO says has proven track record of bringing products

- Has confidence in Serelaxin.

Reaction details (12:14)

- Co. shares move to fresh intra-day highs following these comments in a move higher of 0.48%; trades CHF 57.35 last.

08 Nov 2012 - 12:11 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: